BioCentury’s latest regulatory roundup includes CHMP recommendations, plus FDA approvals for AbbVie, AZ, Lilly, Genentech and Priority Review for Shionogi $JNJ $NVS $ABBV $AZN $LLY $ROG $NBIX https://t.co/IkUefLyYOn